N4 Pharma (LON:N4P) Shares Up 23.8% – Should You Buy?

Shares of N4 Pharma Plc (LON:N4P) were up 23.8% on Thursday . The stock traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.65 ($0.01). Approximately 10,628,002 shares were traded during mid-day trading, an increase of 331% from the average daily volume of 2,466,094 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Stock Performance

The company has a 50 day moving average of GBX 0.62 and a two-hundred day moving average of GBX 0.57. The company has a debt-to-equity ratio of 1.62, a current ratio of 22.73 and a quick ratio of 7.28. The company has a market capitalization of £2.48 million, a PE ratio of -55.00 and a beta of -0.37.

About N4 Pharma

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.